Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Giorgio, Fasolini"'
Autor:
Giorgio Gentile, Fabiola Carrara, Silvia Prandini, Norberto Perico, Giuseppe Remuzzi, Piero Ruggenenti, Andrea Remuzzi, Maria Carolina Aparicio, Luca Barcella, Anna Caroli, Monica Cortinovis, Luca Antiga, Annalisa Perna, Giorgio Fasolini, Davide Martinetti, Flavio Gaspari, Kanishka Sharma, Jorge Arturo Reyes Loaeza, Claudia Patricia Ferrer Siles, Matias Trillini, Nadia Rubis
Publikováno v:
Clinical Journal of the American Society of Nephrology. 11:785-794
The effect of mammalian target of rapamycin (mTOR) inhibitors has never been tested in patients with autosomal dominant polycystic kidney disease (ADPKD) and severe renal insufficiency.In this academic, prospective, randomized, open label, blinded en
Autor:
Giorgio Fasolini, Angelica Spotti, Laura Morali, Carlo Foglia, Eugenia Giraldi, Roberto Agazzi, Massimo Provenzi, Francesco Saettini, Laura Cavalleri
Publikováno v:
Pediatric Hematology and Oncology. 32:223-228
Neuroblastoma presenting with obstructive jaundice is a rare event. Management of this condition includes surgery, chemotherapy, radiotherapy, temporary cholecystostomy tube, endoscopic retrograde cholangiopancreatography (ERCP), and internal biliary
Autor:
Laura Pezzoli, Maria Iascone, Maria Elena Sana, Giovanna Mangili, Paolo Ferrazzi, Paolo Emilio Bianchi, Flavia Fabiani, Youcef Sadou, Daniela Marchetti, Anna Locatelli, Giorgio Fasolini
Publikováno v:
Circulation. 126:2764-2768
A female newborn was referred at birth to our hospital because of respiratory distress. Her family history was unremarkable except for the first-degree consanguinity of her parents. She had a mildly dysmorphic appearance, generalized hypotonia, and s
Autor:
Anna Caroli, Patrizia Ondei, Luca Antiga, Sara Conti, Giorgio Fasolini, Giuseppe Remuzzi, Andrea Remuzzi, Aurelio Sonzogni, Norberto Perico
Publikováno v:
The American Journal of Pathology. 179:619-627
Total kidney and cyst volumes have been used to quantify disease progression in autosomal dominant polycystic kidney disease (ADPKD), but a causal relationship with progression to renal failure has not been demonstrated. Advanced image processing rec
Autor:
Anna Caroli, Luca Antiga, Mariateresa Cafaro, Giuseppe Remuzzi, Andrea Remuzzi, Giorgio Fasolini, Piero Ruggenenti
Publikováno v:
Clinical Journal of the American Society of Nephrology. 5:783-789
Background and objectives: No medical treatment is available for polycystic liver disease, a frequent manifestation of autosomal-dominant polycystic kidney disease (ADPKD). In a prospective, randomized, double-blind, crossover study, 6 months of octr
Autor:
Maria, Dieli, Caterina, Simon, Antonio, Brucato, Patrizia, Pedrotti, Tiziano, Colombo, Antonella, Moreo, Giorgio, Fasolini, Mauro, Gori, Maurizio, Gori, Andrea, Gianatti, Giuseppe, Medolago, Paolo, Ferrazzi
Publikováno v:
Circulation. 127
A 41-year-old man with a partially cystic cardiac mass was referred to our institutions. About 17 years previously, he had undergone the excision of a lipoma in the left popliteal region. The patient had been well until 3 to 4 months earlier, when dy
Autor:
Giorgio Fasolini, Mariateresa Cafaro, Giuseppe Remuzzi, Flavio Gaspari, Andrea Remuzzi, Sergio Carminati, Nadia Rubis, Olimpia Diadei, Silvia Prandini, Anna Caroli, Bogdan Ene-Iordache, Giulia Gherardi, Monica Cortinovis, Luca Antiga, Rodolfo Flores Bravo, Norberto Perico, Piero Ruggenenti, Felipe Rodriguez De Leon, Andrea Panozo, Nicola Motterlini, Patrizia Ondei
Activation of mammalian target of rapamycin (mTOR) pathways may contribute to uncontrolled cell proliferation and secondary cyst growth in patients with autosomal dominant polycystic kidney disease (ADPKD). To assess the effects of mTOR inhibition on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4baae2178422c3909af6737018c5f034
http://hdl.handle.net/10446/23875
http://hdl.handle.net/10446/23875
Autor:
Patrizia Ondei, Luca Antiga, Giorgio Fasolini, Giuseppe Remuzzi, Marina Piccinelli, Andrea Remuzzi, Simona Bruno, Bogdan Ene-Iordache
At the moment, there are no effective therapies to prevent or slow the progression of autosomal dominant polycystic kidney disease (ADPKD). Radiologic evaluations are used to monitor volume of renal cysts and parenchyma during disease evolution. Volu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe06a8daf31f51d426131030bfb0fa3
http://hdl.handle.net/10446/23842
http://hdl.handle.net/10446/23842
Autor:
Piero Ruggenenti, Patrizia Ondei, Giuseppe Remuzzi, Andrea Remuzzi, Luca Antiga, Franklin H. Epstein, Giorgio Fasolini, Bogdan Ene-Iordache
Publikováno v:
Kidney international. 68(1)
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.BackgroundThe fluid filling renal cysts in human polycystic kidneys is secreted chiefly by the tubular epithelium lining the cysts via secondary